Needham & Company Reiterates a Buy Rating as GenMark Diagnostics (GNMK) Reports 4Q Results Consistent with Preannouncement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
GenMark Diagnostics (GNMK) Tops Q4 EPS by 6c
February 23, 2016 4:42 PM ESTGenMark Diagnostics (NASDAQ: GNMK) reported Q4 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $13.2 million versus the consensus estimate of $12.3 million.
For earnings history and earnings-related data on GenMark Diagnostics (GNMK) click here.
... MoreTrading Radar for 2/23: Home Depot (HD), Macy's (M), Ecolab (ECL), Toll Brothers (TOL), First Solar (FSLR) Report
February 22, 2016 3:20 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
9:00am EST
Earnings:
AAC Holdings (NYSE: AAC) - consensus EPS $0.18
AIXTRON SE (Nasdaq: AIXG) - consensus loss $0.01
ANI Pharma (Nasdaq: ANIP) - consensus EPS $0.60
ARIAD Pharma (Nasdaq: ARIA) - consensus loss $0.31
AerCap Holdings (NYSE: AER) -... More
